Hepatotoxicity and -carcinogenicity of the fumonisins in rats. A review regarding mechanistic implications for establishing risk in humans.
Cancer induction by the non-genotoxic mycotoxin, fumonisin B1, has been investigated by studying the mechanisms involved during cancer initiation and promotion in rat liver. Cancer initiation is effected through a toxic-proliferative response while the inhibitory effect on hepatocyte cell proliferation appears to be a key aspect determining cancer promotion. Dose-response effects of the fumonisins on the induction of early neoplastic lesions in both long- and short-term animal experiments have been established. The biphasic response of FB1 on hepatocyte proliferation will be discussed in relation to the known mechanisms of cancer induction by the genotoxic hepatocarcinogens. Recent investigations regarding the effect of the fumonisins on lipid biosynthesis and its inhibitory effect on hepatocyte growth stimulatory responses in vitro will be highlighted. Integration of our current knowledge regarding the carcinogenic potential of the fumonisins in setting a realistic and applicable risk assessment model for this non-genotoxic carcinogen will finally be addressed.
Gelderblom
W C
WC
Programme on Mycotoxins and Experimental Carcinogenesis, Tygerberg, South Africa.
Snyman
S D
SD
Abel
S
S
Lebepe-Mazur
S
S
Smuts
C M
CM
Van der Westhuizen
L
L
Marasas
W F
WF
Victor
T C
TC
Knasmüller
S
S
Huber
W
W
D000818:Animals; D002274:Carcinogens, Environmental / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury; D037341:Fumonisins; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D009183:Mycotoxins / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D051381:Rats; D012307:Risk Factors
D002274:Carcinogens, Environmental; D037341:Fumonisins; D009183:Mycotoxins; C056933:fumonisin B1